Very interesting nature.com/articles/s41593-0…
microviro&beers retweeted
Lifestyle strategies and mechanistic implications for slowing neurodegeneration
nature.com/articles/s44324-0…
microviro&beers retweeted
The turning point for rare diseases, which affect >300 million people around the world.
A call to get rid of its many structural obstacles, to consider it as molecular surgery unlike drug treatments
gift link:
nytimes.com/2026/04/09/opini…
microviro&beers retweeted
Human #neuroimaging data across five major #psychedelics reveal a convergent #brain signature, highlighting a shared pattern of large-scale network #reorganization. These findings help understand how #psychedelic compounds reshape brain architecture. nature.com/articles/s41591-0…
microviro&beers retweeted
We should be prioritizing prevention of cancer instead of the major focus on detection and treatment. A new @CellCellPress perspective
cell.com/cell/fulltext/S0092…
This is really cool (and wild):
Scientists simulated a complete living cell for the first time. Every molecule, every reaction, from DNA replication to cell division.
The paper (Luthey-Schulten et al., Cell 2026, doi.org/10.1016/j.cell.2026.…), just out today, used JCVI-Syn3A — a synthetic minimal bacterium with fewer than 500 genes. A 3D+time simulation of the full 105-minute cell cycle: DNA replication, protein translation, metabolism, division. Every gene, protein, RNA, and chemical reaction tracked through physical space.
It took years to build. Multiple GPUs. Six days of compute time per run.
And this is the simplest possible cell.
A human cell has ~20,000 genes. It lives in tissue. It interacts with neighbors. It differentiates. It responds to drugs in ways that depend on context we haven't fully measured.
Mechanistic simulation of the minimal cell costs 6 GPU-days for 105 minutes of biology. You cannot scale that to human cells. The complexity isn't 40x harder. It's exponentially harder.
This is why the field pivoted to data-driven models. You can't hand-encode the regulatory wiring of a human hepatocyte. But you can learn it — if you have the right perturbation data collected across enough diverse biological contexts.
The two approaches aren't competing. Papers like this generate the ground truth that future ML models need for validation. But the path to a clinically useful virtual cell runs through foundation models, not through scaling up mechanistic simulation.
Amazing work!








